CERID facilitates research on emerging and re-emerging infectious diseases.
SARS, Zika Virus, new influenza strains and other emerging diseases require rapid study and cross-disciplinary collaboration to prevent and manage new epidemics.
CERID experts are equipped with the knowledge, skills and equipment to make a difference.
Already experts in their respective fields of immunology, pathogenesis, drug discovery, translational research and more; CERID researchers are poised to continue making great strides in our understanding of not only the pathogens and agents that cause these ongoing epidemics, but also their transmission mechanisms and vulnerabilities.
CERID labs are located at the University of Washington's South Lake Union medical research campus.
More than 100 Researchers
CERID is multidisciplinary, with over a hundred researchers working together from University of Washington (UW) Departments of Medicine, Pathology, Microbiology, Laboratory Medicine, and Global Health as well as from Washington State University (Center for Global Animal Health) and Washington State Public Health.
Collaboration & Synergy
CERID facilitates collaboration and synergy. We support researchers’ efforts to tackle new pathogens as they emerge on the world stage. This is key to responding effectively to a rapidly changing infectious disease landscape.